Özet:

Macular edema is the most important cause of vision loss at the disease such as diabetic retinopathy, retinal vein root or branch occlusion, age related macular degeneration and uveitis. In our study, the findings from 50 eyes of 46 patients with the implementation of one dose intravitreal dexamethasone (IVD) diagnosed of retinal vein root or branch occlusion, diabetic retinopathy and macular edema related to non-enfective posterior uveitis, followed up at least 6 months after injection were evaluated retrospectively. Patients were evaluated of best corrected visual acuity (BCVA) and central macular thickness (CMT) before injection and 7th day, 1th, 2nd, 3th and 6th months after injection All patients mean CMT and BCVA outcomes were compared before injection with 7th day, 1th, 2nd, 3th and 6th months after injection and the results were statistically significant (p < 0.05).The maximum decreasing of CMT and increasing of BCVA were stated at 2nd month in all patients and subgroups and it was statistically significant (p < 0.05).Decreasing of CMT and increasing of BCVA detected on 2nd month at all patients and subgroups continued up to 6th month descendingly. Cataract occurence has watched in 6-month- follow up at 3 of 43 phakic patients (%6.9) and they were operated because of that reason. As a result, one dose IVD implant injection was founded effective to decrease ma cular edema up to 6 months

Anahtar Kelimeler: